NR565 ADVANCED PHARMACOLOGY MIDTERM EXAM
2026/2027 | Rated A Review | Chamberlain | Pass Guaranteed
- A+ Graded
SECTION 1: PHARMACOKINETICS & PHARMACODYNAMICS
FUNDAMENTALS
Q1: A 58-year-old patient with cirrhosis is prescribed propranolol for portal
hypertension. The nurse practitioner recognizes that first-pass metabolism will be
significantly reduced. Which pharmacokinetic parameter is most directly affected by
this hepatic impairment?
A. Volume of distribution will decrease due to reduced plasma protein synthesis.
B. Bioavailability will increase because less drug is extracted by the liver before
systemic circulation.
C. Renal clearance will double due to compensatory mechanisms.
D. Half-life will shorten because hepatic enzymes are more active in cirrhosis.
Correct Answer: B
Rationale: First-pass metabolism occurs when the liver metabolizes a drug absorbed
from the GI tract before it reaches systemic circulation; in cirrhosis, reduced hepatic
blood flow and enzymatic activity decrease this extraction, thereby increasing
bioavailability. Option A is incorrect because while protein binding may be altered, it is
not the most direct effect of reduced first-pass metabolism. Option C is incorrect
because renal clearance does not compensatorily double in hepatic failure. Option D is
incorrect because half-life typically prolongs, not shortens, in hepatic impairment due to
reduced metabolism. RATED A ✓
Q2: A patient receiving oral nitroglycerin experiences no therapeutic effect. The nurse
practitioner understands that this is primarily due to which pharmacokinetic
phenomenon?
A. High volume of distribution causing drug sequestration in tissues.
,B. Extensive first-pass metabolism by the liver, rendering the drug inactive before
reaching systemic circulation.
C. Ion trapping in the gastric mucosa preventing absorption.
D. Rapid renal excretion before therapeutic plasma concentrations are achieved.
Correct Answer: B
Rationale: Nitroglycerin undergoes extensive first-pass hepatic metabolism, with up to
99% being extracted before reaching the systemic circulation, which is why it is
administered sublingually or transdermally to bypass the portal circulation. Option A is
incorrect because nitroglycerin has a relatively small volume of distribution. Option C is
incorrect because ion trapping is not relevant to nitroglycerin's lack of oral efficacy.
Option D is incorrect because renal excretion is not the primary reason for its oral
ineffectiveness. RATED A ✓
Q3: A 70-year-old patient with heart failure is started on digoxin. The nurse practitioner
calculates the loading dose based on the volume of distribution (Vd). Which statement
best describes the clinical significance of Vd?
A. Vd represents the actual physical volume of blood in which the drug is distributed.
B. Vd is a proportionality constant that relates the amount of drug in the body to the
plasma concentration.
C. Vd is inversely proportional to the drug's lipophilicity.
D. Vd determines the rate of drug absorption from the GI tract.
Correct Answer: B
Rationale: Volume of distribution is a theoretical proportionality constant (Vd = Amount
of drug in body / Plasma concentration) that indicates how extensively a drug
distributes into tissues relative to plasma; it does not represent an actual physiological
volume. Option A is incorrect because Vd is not a real physical volume. Option C is
incorrect because lipophilic drugs typically have larger Vd values, not smaller. Option D
is incorrect because absorption rate is determined by formulation and membrane
permeability, not Vd. RATED A ✓
Q4: A patient asks how long it will take for their new antihypertensive medication to
reach steady-state concentration. The nurse practitioner explains that steady-state is
generally achieved after how many half-lives?
A. 1 to 2 half-lives.
,B. 3 to 4 half-lives.
C. 4 to 5 half-lives.
D. 10 to 12 half-lives.
Correct Answer: C
Rationale: Steady-state concentration is achieved when the rate of drug administration
equals the rate of elimination, which clinically occurs after approximately 4 to 5
half-lives, at which point approximately 94-97% of steady-state is reached. Option A is
incorrect because only 50-75% of steady-state is reached after 1-2 half-lives. Option B is
incorrect because 3-4 half-lives only achieves 87.5-93.75% of steady-state. Option D is
incorrect because 10-12 half-lives far exceeds the time needed to reach steady-state.
RATED A ✓
Q5: A patient with atrial fibrillation on warfarin is started on amiodarone. The nurse
practitioner anticipates which change in warfarin dosing requirements?
A. Warfarin dose will need to be increased due to CYP450 enzyme induction.
B. Warfarin dose will need to be decreased due to CYP2C9 inhibition by amiodarone.
C. No dose adjustment is needed because amiodarone does not affect the CYP450
system.
D. Warfarin dose will need to be increased due to increased vitamin K absorption.
Correct Answer: B
Rationale: Amiodarone is a potent inhibitor of CYP2C9 and CYP1A2, which are
responsible for metabolizing warfarin; inhibition decreases warfarin clearance,
increasing INR and bleeding risk, necessitating a dose reduction. Option A is incorrect
because amiodarone is an inhibitor, not an inducer. Option C is incorrect because
amiodarone significantly affects multiple CYP450 enzymes. Option D is incorrect
because amiodarone does not increase vitamin K absorption. RATED A ✓
Q6: A patient on carbamazepine for epilepsy is started on a new oral contraceptive. The
nurse practitioner counsels the patient that contraceptive efficacy may be reduced due
to which mechanism?
A. Carbamazepine inhibits CYP3A4, increasing estrogen metabolism.
B. Carbamazepine induces CYP3A4, increasing estrogen metabolism and reducing
bioavailability.
C. Carbamazepine displaces estrogen from plasma proteins, increasing its clearance.
, D. Carbamazepine blocks P-glycoprotein, preventing estrogen absorption.
Correct Answer: B
Rationale: Carbamazepine is a potent CYP3A4 inducer that accelerates the metabolism
of ethinyl estradiol and progestins in oral contraceptives, reducing their systemic
exposure and contraceptive efficacy. Option A is incorrect because carbamazepine
induces, not inhibits, CYP3A4. Option C is incorrect because protein displacement is not
the primary mechanism of this interaction. Option D is incorrect because P-glycoprotein
inhibition would increase, not decrease, drug absorption. RATED A ✓
Q7: A patient taking simvastatin is advised to avoid grapefruit juice. The nurse
practitioner explains that grapefruit juice increases statin toxicity through which
mechanism?
A. Grapefruit juice induces CYP3A4, increasing statin metabolism to toxic metabolites.
B. Grapefruit juice inhibits intestinal CYP3A4 and P-glycoprotein, increasing statin
bioavailability.
C. Grapefruit juice displaces statins from albumin binding sites.
D. Grapefruit juice alkalinizes urine, reducing statin renal excretion.
Correct Answer: B
Rationale: Grapefruit juice contains furanocoumarins that irreversibly inhibit intestinal
CYP3A4 and P-glycoprotein, significantly increasing the bioavailability of CYP3A4
substrates like simvastatin and atorvastatin, thereby increasing myopathy risk. Option A
is incorrect because grapefruit juice inhibits, not induces, CYP3A4. Option C is incorrect
because protein displacement is not the mechanism of this interaction. Option D is
incorrect because urine alkalinization is not relevant to statin pharmacokinetics. RATED
A✓
Q8: A patient on digoxin develops toxicity after starting clarithromycin for pneumonia.
The nurse practitioner recognizes that clarithromycin increases digoxin levels primarily
through which mechanism?
A. Inhibition of P-glycoprotein-mediated efflux of digoxin from intestinal cells and renal
tubules.
B. Induction of CYP3A4, which is the primary metabolic pathway for digoxin.
C. Displacement of digoxin from tissue binding sites in the myocardium.
D. Increased gastric acid secretion enhancing digoxin absorption.
2026/2027 | Rated A Review | Chamberlain | Pass Guaranteed
- A+ Graded
SECTION 1: PHARMACOKINETICS & PHARMACODYNAMICS
FUNDAMENTALS
Q1: A 58-year-old patient with cirrhosis is prescribed propranolol for portal
hypertension. The nurse practitioner recognizes that first-pass metabolism will be
significantly reduced. Which pharmacokinetic parameter is most directly affected by
this hepatic impairment?
A. Volume of distribution will decrease due to reduced plasma protein synthesis.
B. Bioavailability will increase because less drug is extracted by the liver before
systemic circulation.
C. Renal clearance will double due to compensatory mechanisms.
D. Half-life will shorten because hepatic enzymes are more active in cirrhosis.
Correct Answer: B
Rationale: First-pass metabolism occurs when the liver metabolizes a drug absorbed
from the GI tract before it reaches systemic circulation; in cirrhosis, reduced hepatic
blood flow and enzymatic activity decrease this extraction, thereby increasing
bioavailability. Option A is incorrect because while protein binding may be altered, it is
not the most direct effect of reduced first-pass metabolism. Option C is incorrect
because renal clearance does not compensatorily double in hepatic failure. Option D is
incorrect because half-life typically prolongs, not shortens, in hepatic impairment due to
reduced metabolism. RATED A ✓
Q2: A patient receiving oral nitroglycerin experiences no therapeutic effect. The nurse
practitioner understands that this is primarily due to which pharmacokinetic
phenomenon?
A. High volume of distribution causing drug sequestration in tissues.
,B. Extensive first-pass metabolism by the liver, rendering the drug inactive before
reaching systemic circulation.
C. Ion trapping in the gastric mucosa preventing absorption.
D. Rapid renal excretion before therapeutic plasma concentrations are achieved.
Correct Answer: B
Rationale: Nitroglycerin undergoes extensive first-pass hepatic metabolism, with up to
99% being extracted before reaching the systemic circulation, which is why it is
administered sublingually or transdermally to bypass the portal circulation. Option A is
incorrect because nitroglycerin has a relatively small volume of distribution. Option C is
incorrect because ion trapping is not relevant to nitroglycerin's lack of oral efficacy.
Option D is incorrect because renal excretion is not the primary reason for its oral
ineffectiveness. RATED A ✓
Q3: A 70-year-old patient with heart failure is started on digoxin. The nurse practitioner
calculates the loading dose based on the volume of distribution (Vd). Which statement
best describes the clinical significance of Vd?
A. Vd represents the actual physical volume of blood in which the drug is distributed.
B. Vd is a proportionality constant that relates the amount of drug in the body to the
plasma concentration.
C. Vd is inversely proportional to the drug's lipophilicity.
D. Vd determines the rate of drug absorption from the GI tract.
Correct Answer: B
Rationale: Volume of distribution is a theoretical proportionality constant (Vd = Amount
of drug in body / Plasma concentration) that indicates how extensively a drug
distributes into tissues relative to plasma; it does not represent an actual physiological
volume. Option A is incorrect because Vd is not a real physical volume. Option C is
incorrect because lipophilic drugs typically have larger Vd values, not smaller. Option D
is incorrect because absorption rate is determined by formulation and membrane
permeability, not Vd. RATED A ✓
Q4: A patient asks how long it will take for their new antihypertensive medication to
reach steady-state concentration. The nurse practitioner explains that steady-state is
generally achieved after how many half-lives?
A. 1 to 2 half-lives.
,B. 3 to 4 half-lives.
C. 4 to 5 half-lives.
D. 10 to 12 half-lives.
Correct Answer: C
Rationale: Steady-state concentration is achieved when the rate of drug administration
equals the rate of elimination, which clinically occurs after approximately 4 to 5
half-lives, at which point approximately 94-97% of steady-state is reached. Option A is
incorrect because only 50-75% of steady-state is reached after 1-2 half-lives. Option B is
incorrect because 3-4 half-lives only achieves 87.5-93.75% of steady-state. Option D is
incorrect because 10-12 half-lives far exceeds the time needed to reach steady-state.
RATED A ✓
Q5: A patient with atrial fibrillation on warfarin is started on amiodarone. The nurse
practitioner anticipates which change in warfarin dosing requirements?
A. Warfarin dose will need to be increased due to CYP450 enzyme induction.
B. Warfarin dose will need to be decreased due to CYP2C9 inhibition by amiodarone.
C. No dose adjustment is needed because amiodarone does not affect the CYP450
system.
D. Warfarin dose will need to be increased due to increased vitamin K absorption.
Correct Answer: B
Rationale: Amiodarone is a potent inhibitor of CYP2C9 and CYP1A2, which are
responsible for metabolizing warfarin; inhibition decreases warfarin clearance,
increasing INR and bleeding risk, necessitating a dose reduction. Option A is incorrect
because amiodarone is an inhibitor, not an inducer. Option C is incorrect because
amiodarone significantly affects multiple CYP450 enzymes. Option D is incorrect
because amiodarone does not increase vitamin K absorption. RATED A ✓
Q6: A patient on carbamazepine for epilepsy is started on a new oral contraceptive. The
nurse practitioner counsels the patient that contraceptive efficacy may be reduced due
to which mechanism?
A. Carbamazepine inhibits CYP3A4, increasing estrogen metabolism.
B. Carbamazepine induces CYP3A4, increasing estrogen metabolism and reducing
bioavailability.
C. Carbamazepine displaces estrogen from plasma proteins, increasing its clearance.
, D. Carbamazepine blocks P-glycoprotein, preventing estrogen absorption.
Correct Answer: B
Rationale: Carbamazepine is a potent CYP3A4 inducer that accelerates the metabolism
of ethinyl estradiol and progestins in oral contraceptives, reducing their systemic
exposure and contraceptive efficacy. Option A is incorrect because carbamazepine
induces, not inhibits, CYP3A4. Option C is incorrect because protein displacement is not
the primary mechanism of this interaction. Option D is incorrect because P-glycoprotein
inhibition would increase, not decrease, drug absorption. RATED A ✓
Q7: A patient taking simvastatin is advised to avoid grapefruit juice. The nurse
practitioner explains that grapefruit juice increases statin toxicity through which
mechanism?
A. Grapefruit juice induces CYP3A4, increasing statin metabolism to toxic metabolites.
B. Grapefruit juice inhibits intestinal CYP3A4 and P-glycoprotein, increasing statin
bioavailability.
C. Grapefruit juice displaces statins from albumin binding sites.
D. Grapefruit juice alkalinizes urine, reducing statin renal excretion.
Correct Answer: B
Rationale: Grapefruit juice contains furanocoumarins that irreversibly inhibit intestinal
CYP3A4 and P-glycoprotein, significantly increasing the bioavailability of CYP3A4
substrates like simvastatin and atorvastatin, thereby increasing myopathy risk. Option A
is incorrect because grapefruit juice inhibits, not induces, CYP3A4. Option C is incorrect
because protein displacement is not the mechanism of this interaction. Option D is
incorrect because urine alkalinization is not relevant to statin pharmacokinetics. RATED
A✓
Q8: A patient on digoxin develops toxicity after starting clarithromycin for pneumonia.
The nurse practitioner recognizes that clarithromycin increases digoxin levels primarily
through which mechanism?
A. Inhibition of P-glycoprotein-mediated efflux of digoxin from intestinal cells and renal
tubules.
B. Induction of CYP3A4, which is the primary metabolic pathway for digoxin.
C. Displacement of digoxin from tissue binding sites in the myocardium.
D. Increased gastric acid secretion enhancing digoxin absorption.
